SLIDE 1
This presentation and all other information, materials or documents provided in connection therewith, must not be photocopied or reproduced or distributed to any other person in whole or in part at any time except with Praram 9 Hospital Public Company Limited (“PR9”) prior written consent. These materials have been prepared by PR9 solely for use at a presentation for this meeting. No representations, warranties, or undertakings, express or implied, are made by PR9, or any of their respective members, directors, officers, employees, agents, affiliates, advisers or representatives or any other person as to, and no reliance should be placed
- n, the fairness, accuracy, completeness or correctness of, the information or opinions presented or contained in these materials. By attending this presentation, you are agreeing
to be bound by the restrictions set out below. Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The contents of these materials have not been verified by PR9 and it may not contain all material information concerning PR9. None of PR9, or any of their respective directors,
- fficers, employees, agents, affiliates, advisers or representatives accepts any liability whatsoever in negligence or otherwise for any loss howsoever arising, whether directly or
indirectly, from any use of the information or opinions presented or contained in these materials or otherwise arising in connection with these materials. The information and
- pinions presented or contained in these materials are provided as at the date of this presentation based on the economic, regulatory, market and other conditions as in effect on
the date hereof and are subject to verification, completion, updating, revision and change without notice and the accuracy of the information is not guaranteed. It should be understood that subsequent developments may affect the information and opinions presented or contained in these materials, which neither PR9 nor its advisers or representatives are under an obligation to update, revise or affirm. This presentation may contain “forward-looking statements” as well as “unaudited forecasts” and “projected financial information” (“Forward-Looking Statements”), which (i) address hypothetical situation, (ii) are based on current expectations and projections about future events, or (iii) include all statements other than statements of historical facts, as well as predictions, projections and forecasts of the economy or economic trends of the markets. Such Forward-Looking Statements are not necessarily indicative of the future or likely performance or projection of PR9 and involve known and unknown risks, uncertainties and other important factors beyond the control of PR9 that could cause the actual results, performance or achievements or industry results to be materially different from future results, performance or achievements expressed or implied by such Forward- Looking Statements. Such Forward-Looking Statements are based on forecasts and projections from PR9. Forward-Looking Statements are not guarantees of future performance and speak only as at the date of this presentation, and none of PR9, or any of their respective directors, officers, employees, agents, affiliates, advisers or representatives intends or has any
- bligation or undertakes to supplement, amend, update or revise any forward-looking statements as a result of new information or to reflect future events or circumstances,
except as required under applicable laws. You should not place undue reliance on these Forward-Looking Statements. Past performance is not necessarily indicative of future performance. No part of this presentation and the information contained in these materials shall constitute or form part of any advertisement of, commitment or offer or invitation of any offer for sale or subscription of or solicitation or recommendation or invitation of any offer to buy or subscribe for, any securities of PR9 in any jurisdiction nor shall it or any part of it form the basis of or be relied on in connection with any contract or commitment whatsoever. No consideration has been given to particular investment objectives, finances or needs of any recipient. This presentation should not be treated or relied upon as advice relating to legal, taxation, financial, accounting, investment matters or advice or a credit or other evaluation of the offering for any securities of PR9. By attending this presentation you (i) acknowledge that you will be solely responsible for your own assessment of the market and the market position of PR9, and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of PR9’s business and (ii) agree to be bound by the foregoing terms PR9 and its representatives are not responsible for any costs or expenses incurred by the recipient.
Disclaimer
1
Note: Analyst Presentation 3Q18 & 9M18 Results as of 15 November 2018